Recent advances in the understanding of the molecular pathogenesis of
cancer herald breakthroughs in the treatment of this collection of dis
eases, which are still usually incurable in advanced stages. In partic
ular, there is a high expectation of gene and immunogene therapy. A re
cent meeting surveyed new progress in this area.